Cannabis-specialising biopharmaceuticals company Tetra Bio-Pharma has appointed Edward Miller as Vice President, Investor Relations and Corporate Communications.
Miller has over a decade of experience in the Biotech/Pharma industry. Most recently, he served as Director, Investor Relations and Corporate Communications at IntelGenx where he successfully built their shareholder communications program, resulting in substantial growth in their website traffic and social media hits.
Miller joined Paladin Labs in 2001 where he held various positions including Manager, Investor Relations. There, he successfully built their investor relations program.
Following his tenure at Paladin Labs he moved into the role as an investor relations consultant working for Christensen IR, heading their life science practice and as an independent where he has built award winning investor relations programs.
Miller is the Past President of CIRI (Canadian Investor Relations Institute) Quebec Chapter where he served two terms. Miller will be contributing to improving the company's visibility in the capital markets and leveraging his international experience at broadening its shareholder base.
Andre Rancourt, CEO of Tetra Bio-Pharma, said: "Miller has built award winning investor relations programs that have driven shareholder value and visibility for several organisations in the market place. We look forward to expanding our communications outreach as we build an even stronger shareholder base moving forwards."
